Molecule of the Month: miRNA and Parkinson’s Disease Protein PARK2

Bioinformation
doi 10.6026/97320630009381
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Biomedical Informatics

Related search

Parkinson’s Disease and Parkin: Insights From Park2 Knockout Mice

2012English

Nonmercaptalbumin as an Oxidative Stress Marker in Parkinson’s and PARK2 Disease

Annals of Clinical and Translational Neurology
NeuroscienceNeurology
2020English

Dementia and Molecule of the Month APP

Bioinformation
2012English

Beneficial Effect of 24-Month Bilateral Subthalamic Stimulation on Quality of Sleep in Parkinson’s Disease

Journal of Neurology
Neurology
2020English

Role of Mitogen Activated Protein Kinase Signaling in Parkinson’s Disease

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2018English

VPS35, the Retromer Complex and Parkinson’s Disease

Journal of Parkinson's Disease
Molecular NeuroscienceNeurologyCellular
2017English

Natural Products for the Therapy of Proteinopathies Underlying the Neurodegenerative Conditions: Protein Misfolding and Fibrillization in Alzheimer’s Disease and Parkinson’s Disease

American Journal of Biomedical Science & Research
2019English

Premorbid Personality and the Risk of Parkinson’s Disease

Journal of Neurology Research
2014English

Neurorehabilitation of Parkinson’s Disease and ALS

NeuroRehabilitation
Physical TherapySports TherapyNeurologyRehabilitation
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy